SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-446310
Filing Date
2013-11-19
Accepted
2013-11-19 09:17:11
Documents
8
Period of Report
2013-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d631498d8k.htm 8-K 41446
2 EX-2.1 d631498dex21.htm EX-2.1 413898
3 EX-10.1 d631498dex101.htm EX-10.1 62738
4 EX-10.2 d631498dex102.htm EX-10.2 68064
5 EX-10.3 d631498dex103.htm EX-10.3 37434
6 EX-10.4 d631498dex104.htm EX-10.4 50442
7 EX-10.5 d631498dex105.htm EX-10.5 52813
8 EX-99.1 d631498dex991.htm EX-99.1 27162
  Complete submission text file 0001193125-13-446310.txt   755206
Mailing Address 2100 SYNTEX COURT MISSISSAUGA A6 L5N 7K9
Business Address C/O PATHEON PHARMACEUTICALS SERVICES INC 4721 EMPEROR BOULEVARD, SUITE 200 DURHAM NC 27703 905-821-4001
PATHEON INC (Filer) CIK: 0001400431 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-54283 | Film No.: 131228752
SIC: 2834 Pharmaceutical Preparations